These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 9121964

  • 1. Implantable cardioverter defibrillator (ICD) is becoming more accepted in the treatment of cardiac arrhythmias.
    Pirzada FA.
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):140-1. PubMed ID: 9121964
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Implantable cardioverter defibrillators in the United States: understanding the benefits and limitations of implantable cardioverter defibrillator therapy based on clinical trial results.
    Gottlieb C, Callans DJ, Marchlinski F.
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 1):2016-20. PubMed ID: 9826851
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis.
    Bernardo P, Conforti ML, Bellando-Randone S, Pieragnoli P, Blagojevic J, Kaloudi O, Guiducci S, Porta F, Padeletti L, Gensini GF, Matucci-Cerinic M.
    J Rheumatol; 2011 Aug; 38(8):1617-21. PubMed ID: 21632680
    [Abstract] [Full Text] [Related]

  • 13. The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions.
    Verma N, Rhyner J, Knight BP.
    Expert Rev Cardiovasc Ther; 2015 Aug; 13(9):989-99. PubMed ID: 26308601
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The subcutaneous implantable cardioverter-defibrillator: should patients want one?
    Hauser RG.
    J Am Coll Cardiol; 2013 Jan 08; 61(1):20-2. PubMed ID: 23122791
    [Abstract] [Full Text] [Related]

  • 16. Sudden cardiac death and channelopathies: a review of implantable defibrillator therapy.
    Choi GR, Porter CB, Ackerman MJ.
    Pediatr Clin North Am; 2004 Oct 08; 51(5):1289-303. PubMed ID: 15331285
    [Abstract] [Full Text] [Related]

  • 17. Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure.
    Sengupta J, Abdelhadi R.
    Curr Opin Cardiol; 2013 May 08; 28(3):337-43. PubMed ID: 23549236
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU, Goldenberg I, Moss AJ.
    Eur Heart J; 2013 Aug 08; 34(29):2230-42. PubMed ID: 23729691
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.